| In millions, except per share items | Sep-30-14 | Sep-30-13 | Sep-30-12 | Sep-30-11 | Sep-30-10 | Sep-30-09 | Sep-30-08 | Sep-30-07 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| GSK License Agreement | | | | | 2.4 | | | |
| Other | | | | | 0.5 | | | |
| Revenues [+] | 115.0 | 75.4 | 41.3 | 10.5 | 2.9 | 8.4 | 0.1 | 0.1 |
| Licensing | | | | | | 0.5 | | |
| Royalties | 2.7 | 4.5 | 4.2 | 4.4 | 2.9 | 3.6 | | |
| Products | 105.4 | 70.7 | 37.1 | 6.1 | | | | |
| Services | 0.1 | 0.2 | | | | | | |
| Other | 6.7 | | | | | 4.2 | | |
| Revenue growth | 52.6% | 82.6% | 293.2% | 262.5% | -65.3% | 6334.3% | 80.3% | 294.1% |
| Cost of goods sold [+] | 3.5 | 4.2 | 2.1 | 0.4 | 0.2 | 0.1 | 0.0 | 0.3 |
| Cost of product sales | 3.3 | 4.0 | | | | | | |
| Cost of services | 0.2 | 0.1 | | | | | | |
| Gross profit | 111.5 | 71.2 | 39.2 | 10.0 | 2.7 | 8.3 | 0.1 | -0.3 |
| Gross margin | 96.9% | 94.5% | 94.9% | 95.8% | 93.2% | 99.1% | 83.3% | -355.8% |
| Selling, general and administrative [+] | 113.8 | 93.1 | 74.5 | 55.4 | 16.5 | 10.2 | 10.6 | 20.8 |
| Sales and marketing | 77.7 | 63.2 | 52.5 | 38.1 | | | | |
| General and administrative | 36.2 | 29.9 | 22.0 | 17.3 | | | | 20.8 |
| Research and development | 44.0 | 49.5 | 23.1 | 15.3 | 13.3 | 15.9 | 14.1 | 13.1 |
| Other operating expenses | | | | | | 4.2 | -5.6 | -4.8 |
| EBITDA [+] | -44.9 | -70.6 | -57.7 | -60.2 | -26.9 | -21.7 | -18.5 | -26.5 |
| EBITDA growth | -36.3% | 22.4% | -4.1% | 123.8% | 24.1% | 17.0% | -30.2% | -45.5% |
| EBITDA margin | -39.1% | -93.7% | -139.8% | -573.5% | -928.8% | -259.4% | -14263.2% | -36840.3% |
| Depreciation and amortization | 1.4 | 0.8 | 0.7 | 0.4 | 0.2 | 0.3 | 0.4 | 2.8 |
| EBIT [+] | -46.3 | -71.4 | -58.4 | -60.6 | -27.1 | -21.9 | -19.0 | -29.4 |
| EBIT growth | -35.1% | 22.3% | -3.7% | 123.8% | 23.6% | 15.6% | -35.4% | -43.2% |
| EBIT margin | -40.3% | -94.8% | -141.5% | -577.6% | -935.8% | -262.5% | -14606.7% | -40790.1% |
| Interest expense, net [+] | 3.3 | 4.0 | 1.3 | 0.0 | 0.0 | -0.2 | -0.7 | 0.6 |
| Interest expense | 3.3 | 4.1 | 1.4 | | | 0.0 | 0.5 | 1.2 |
| Interest income | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 1.3 | 0.6 |
| Other income (expense), net [+] | -0.8 | | 0.0 | 0.0 | 0.4 | -0.3 | 2.3 | 1.6 |
| Gain (loss) on debt retirement | -0.8 | | | | | | 1.0 | |
| Other | 0.0 | | 0.0 | 0.0 | 0.4 | -0.3 | -1.2 | -1.6 |
| Pre-tax income | -50.4 | -75.5 | -59.7 | -60.6 | -26.7 | -22.0 | -15.9 | -28.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | | | | | |
| Earnings from continuing ops | -50.4 | -75.5 | -59.7 | -60.6 | -26.7 | -22.0 | -15.9 | -20.9 |
| Earnings from discontinued ops | | | | | | | -1.4 | 7.4 |
| Net income | -50.4 | -75.5 | -59.7 | -60.6 | -26.7 | -22.0 | -17.5 | -20.9 |
| Net margin | -43.8% | -100.1% | -144.7% | -577.7% | -921.9% | -263.3% | -13476.9% | -29074.2% |
| |
| Basic EPS [+] | ($0.31) | ($0.53) | ($0.45) | ($0.51) | ($0.30) | ($0.28) | ($0.27) | ($0.53) |
| Growth | -41.0% | 18.4% | -11.8% | 66.7% | 9.2% | 3.3% | -48.8% | -74.1% |
| Diluted EPS [+] | ($0.31) | ($0.53) | ($0.45) | ($0.51) | ($0.30) | ($0.28) | ($0.27) | ($0.53) |
| Growth | -41.0% | 18.4% | -11.8% | 66.7% | 9.2% | 3.3% | -48.8% | -74.1% |
| |
| Shares outstanding (basic) [+] | 161.3 | 142.3 | 133.4 | 119.4 | 87.6 | 78.8 | 58.9 | 39.6 |
| Growth | 13.4% | 6.7% | 11.7% | 36.3% | 11.1% | 33.9% | 48.6% | 29.4% |
| Shares outstanding (diluted) [+] | 161.3 | 142.3 | 133.4 | 119.4 | 87.6 | 78.8 | 58.9 | 39.6 |
| Growth | 13.4% | 6.7% | 11.7% | 36.3% | 11.1% | 33.9% | 48.6% | 29.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |